USPTO serial 87766670
VEDIUS
Reviewed by CopyMark Law Group
Status 606
- Filing date
- Status date
- Registration date
- —
- Examiner
- NADELMAN, ANDREA KOYNER
- Law office
- INTENT TO USE SECTION
What this means
This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.
Need help with VEDIUS?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Frank V. Gallucci
Frank V. Gallucci FUJIFILM Holdings America Corporation200 Summit Lake DriveValhalla, NY 10595UNITED STATESGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 001 | Cell cultures used in industry and science; mammalian cell cultures and viral vectors, being independent replicating pieces of DNA that can transfer DNA sequences, each for manufacture and development in the biotechnology industries | ACTIVE | — |
| 040 | Processing and manufacturing of viral vectors, cell cultures, viral vaccines and gene therapy products for use in biotechnology industries to the order and specification of others; manufacture, processing and production of viral vaccines and gene therapy products for use in the biotechnology industries to the order and specification of others | ACTIVE | — |
| 042 | Scientific, industrial and technical research, development and analysis services relating to the use of mammalian cell cultures and viral vectors in the field of biotechnology; process development, namely, development of processes for the use of mammalian cell cultures and viral vectors in the manufacture of viral vaccines and gene therapy products; project studies relating to the use of mammalian cell cultures and viral vectors in the field of viral vaccines and gene therapy | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by FUJIFILM Diosynth Biotechnologies Texas, LLC
- Other trademarks owned by FUJIFILM Diosynth Biotechnologies Texas, LLC
- Other trademarks in Class 001
- Other trademarks in Class 040
- Other trademarks in Class 042
- Similar marks named VEDIUS
- Prosecution event MAB6 explained
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Apr 18, 2022 | MAB6 | ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED | The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window. |
| Apr 18, 2022 | ABN6 | ABANDONMENT - NO USE STATEMENT FILED | The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window. |
| Jul 28, 2021 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Jul 26, 2021 | EX4G | SOU EXTENSION 4 GRANTED | — |
| Jul 26, 2021 | EXT4 | SOU EXTENSION 4 FILED | — |
| Jul 26, 2021 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Feb 20, 2021 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Feb 18, 2021 | EX3G | SOU EXTENSION 3 GRANTED | — |
| Feb 18, 2021 | EXT3 | SOU EXTENSION 3 FILED | — |
| Feb 18, 2021 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Jul 31, 2020 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Jul 29, 2020 | EX2G | SOU EXTENSION 2 GRANTED | — |
| Jul 29, 2020 | EXT2 | SOU EXTENSION 2 FILED | — |
| Jul 29, 2020 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Jan 24, 2020 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Jan 22, 2020 | EX1G | SOU EXTENSION 1 GRANTED | — |
| Jan 22, 2020 | EXT1 | SOU EXTENSION 1 FILED | — |
| Jan 22, 2020 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Sep 17, 2019 | NOAM | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | A Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date. |
| Aug 2, 2019 | TMBN | TTAB RELEASE CASE TO TRADEMARKS | — |
| Aug 2, 2019 | OP.T | OPPOSITION TERMINATED NO. 999999 | — |
| Aug 2, 2019 | OP.D | OPPOSITION DISMISSED NO. 999999 | — |
| Jul 26, 2018 | OP.I | OPPOSITION INSTITUTED NO. 999999 | — |
| Jul 26, 2018 | OPPF | OPPOSITION PAPERS RECEIVED AT TTAB | — |
| Jun 26, 2018 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Jun 26, 2018 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Jun 6, 2018 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| May 18, 2018 | ALIE | ASSIGNED TO LIE | — |
| May 9, 2018 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| May 8, 2018 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| May 8, 2018 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| May 8, 2018 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| May 8, 2018 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| May 8, 2018 | GPRN | NOTIFICATION OF PRIORITY ACTION E-MAILED | A priority action is a type of Office Action the USPTO treats as time-sensitive. It usually means the examining attorney needs a specific response or amendment quickly — often relating to a foreign priority claim or a formal requirement. Respond within the stated deadline. |
| May 8, 2018 | GPRA | PRIORITY ACTION E-MAILED | A priority action is a type of Office Action the USPTO treats as time-sensitive. It usually means the examining attorney needs a specific response or amendment quickly — often relating to a foreign priority claim or a formal requirement. Respond within the stated deadline. |
| May 8, 2018 | CPRA | PRIORITY ACTION WRITTEN | A priority action is a type of Office Action the USPTO treats as time-sensitive. It usually means the examining attorney needs a specific response or amendment quickly — often relating to a foreign priority claim or a formal requirement. Respond within the stated deadline. |
| May 3, 2018 | DOCK | ASSIGNED TO EXAMINER | — |
| Feb 2, 2018 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Jan 26, 2018 | NWAP | NEW APPLICATION ENTERED | — |